Angle (AGL)

Sector:

Support

Index:

FTSE AIM All-Share

14.00p
   
  • Change Today:
      0.25p
  • 52 Week High: 31.40
  • 52 Week Low: 9.25
  • Currency: UK Pounds
  • Shares Issued: 260.58m
  • Volume: 659,855
  • Market Cap: £36.48m
  • RiskGrade: 312
  • Beta: 0.05

Angle completes fundraising and acquisition of Axela

By Ikaba Koyi

Date: Wednesday 01 Nov 2017

LONDON (ShareCast) - (ShareCast News) - The global liquid biopsy company Angle announced on Wednesday the completion of fundraising and acquisition of certain assets of Axela Inc, further to the announcement of 30 October 2017 with general admission having taken place earlier today.
Axela creates tools and content to simplify multiplex biomarker detection for translational research and diagnostic testing.

While ANGLE is known for its Parsortix system, a cell separation technology, which is the subject of granted patents in Europe, the United States, Canada, India, China, Japan and Australia.

The system enables a liquid biopsy (simple blood test) to be used to provide the cells of interest with the analysis of the harvested cells hopefully opening the door to personalised cancer care, according to Angle.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Angle Market Data

Currency UK Pounds
Share Price 14.00p
Change Today 0.25p
% Change 1.82 %
52 Week High 31.40
52 Week Low 9.25
Volume 659,855
Shares Issued 260.58m
Market Cap £36.48m
Beta 0.05
RiskGrade 312

Angle Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
8.3% below the market average8.3% below the market average8.3% below the market average8.3% below the market average8.3% below the market average
40.00% above the sector average40.00% above the sector average40.00% above the sector average40.00% above the sector average40.00% above the sector average
Price Trend
45.91% below the market average45.91% below the market average45.91% below the market average45.91% below the market average45.91% below the market average
64% below the sector average64% below the sector average64% below the sector average64% below the sector average64% below the sector average
Income Not Available
Growth
13.9% below the market average13.9% below the market average13.9% below the market average13.9% below the market average13.9% below the market average
11.11% below the sector average11.11% below the sector average11.11% below the sector average11.11% below the sector average11.11% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Angle Dividends

No dividends found

Trades for 01-May-2024

Time Volume / Share Price
15:10 30,000 @ 14.00p
13:31 3,280 @ 13.72p
12:39 666 @ 13.60p
12:18 50,000 @ 13.73p
12:12 40,000 @ 13.70p

Angle Key Personnel

CEO Andrew D Newland
Finance Director Ian F Griffiths
Chair Jan Groen

Top of Page